Minimal physiologically‐based hybrid model of pharmacokinetics in pregnant women: Application to antenatal corticosteroids
Open Access
- 14 March 2023
- journal article
- research article
- Published by Wiley in CPT: Pharmacometrics & Systems Pharmacology
- Vol. 12 (5) , 668-680
Abstract
Minimal physiologically‐based pharmacokinetic (mPBPK) models are an alternative to full physiologically‐based pharmacokinetic (PBPK) models as they offer reduced complexity while maintaining the physiological interpretation of key model components. Full PBPK models have been developed for pregnancy, but a mPBPK model eases the ability to perform a “top‐down” meta‐analysis melding all available pharmacokinetic (PK) data in the mother and fetus. Our hybrid mPBPK model consists of mPBPK models for the mother and fetus with connection by the placenta. This model was applied to describe the rich PK data of antenatal corticosteroid betamethasone (BET) jointly with the limited data for dexamethasone (DEX) in the mother and fetus. Physiologic model parameters were obtained from the literature while drug‐dependent parameters were estimated by the simultaneous fitting of all available data for DEX and BET. Maternal clearances of DEX and BET confirmed the literature values, and the expected fetal‐to‐maternal plasma ratios ranged from 0.3 to 0.4 for both drugs. Simulations of maternal plasma concentrations for the dosing regimens of BET and DEX recommended by the World Health Organization based on our findings revealed up to 60% lower exposures than found in nonpregnant women and offers a means of devising alternative dosing regimens. Our hybrid mPBPK model and meta‐analysis approach could facilitate assessment of other classes of drugs indicated for the treatment of pregnant women.Keywords
This publication has 40 references indexed in Scilit:
- A Simplified PBPK Modeling Approach for Prediction of Pharmacokinetics of Four Primarily Renally Excreted and CYP3A Metabolized Compounds During PregnancyThe AAPS Journal, 2013
- Applications of minimal physiologically-based pharmacokinetic modelsJournal of Pharmacokinetics and Pharmacodynamics, 2012
- Application of quantitative structure–activity relationships for modeling drug and chemical transport across the human placenta barrier: a multivariate data analysis approachJournal of Applied Toxicology, 2009
- Developmental Expression of the Major Human Hepatic CYP3A EnzymesThe Journal of Pharmacology and Experimental Therapeutics, 2003
- In vivo and in vitro induction of human cytochrome P4503A4 by dexamethasoneClinical Pharmacology & Therapeutics, 2000
- Body Composition Measurements During Pregnancy1993
- Disposition of betamethasone in parturient women after intramuscular administration.British Journal of Clinical Pharmacology, 1984
- Disposition of betamethasone in parturient women after intravenous administrationEuropean Journal of Clinical Pharmacology, 1983
- The placental transfer of betamethasoneEuropean Journal of Clinical Pharmacology, 1980
- Glucocorticoid levels in maternal and cord serum after prenatal betamethasone therapy to prevent respiratory distress syndrome.Journal of Clinical Investigation, 1975